| Cascade testing for elevated lipoprotein (a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein (a) A Chakraborty, J Pang, DC Chan, KL Ellis, AJ Hooper, DA Bell, JR Burnett, ... Atherosclerosis 349, 219-226, 2022 | 13 | 2022 |
| Cascade testing for elevated lipoprotein (a) in relatives of probands with high lipoprotein (a) A Chakraborty, DC Chan, KL Ellis, J Pang, W Barnett, AM Woodward, ... American Journal of Preventive Cardiology 10, 100343, 2022 | 12 | 2022 |
| Effectiveness of proprotein convertase subtilisin/kexin‐9 monoclonal antibody treatment on plasma lipoprotein (a) concentrations in patients with elevated lipoprotein (a … A Chakraborty, J Pang, DC Chan, W Barnett, AM Woodward, M Vorster, ... Clinical Cardiology 44 (6), 805-813, 2021 | 6 | 2021 |
| Analysis of risk factors for hypoglycemic coma in 194 patients with type 2 diabetes Z Lu, J Liu, Q He, A Chakraborty, T Zhu Medical science monitor: international medical journal of experimental and …, 2017 | 5 | 2017 |
| To test, or not to test: that is the question for the future of lipoprotein (a) KL Ellis, A Chakraborty, EK Moses, GF Watts Expert Review of Cardiovascular Therapy 17 (4), 241-250, 2019 | 4 | 2019 |
| A case of pituitary stalk interruption syndrome with intermittent seizures as the first presentation J Li, H Jia, A Chakraborty, Z Gao Neuroendocrinology Letters 37 (7), 2016 | 3 | 2016 |
| Cascade testing of elevated Lp (a) in children and adolescents via the familial hypercholesterolemia screening program WJ Loh, J Pang, A Chakraborty, N Ward, D Chan, A Hooper, D Bell, ... Atherosclerosis 379, S118, 2023 | | 2023 |
| Exploring Health Literacy Among Patients With Elevated Lipoprotein (a) A Chakraborty, N How, J Pang, K Ellis, D Chan, G Watts Heart, Lung and Circulation 32, S315, 2023 | | 2023 |
| High Prevalence of Lipid-Related Residual Risk in ACS Patients NC Ward, J Pang, A Chakraborty, C Schultz, D Chan, GF Watts Heart, Lung and Circulation 31 (2), e20-e21, 2022 | | 2022 |
| Hyperlipoprotein (a): Risk Prediction, Detection, and Treatment A Chakraborty | | 2022 |
| Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein (a) in patients with elevated lipoprotein (a) attending a clinic A Chakraborty, J Pang, DC Chan, GF Watts Atherosclerosis 331, e119-e120, 2021 | | 2021 |
| Cardiovascular and behavioural risk factors in families with elevated lipoprotein (a)[Lp (a)] A Chakraborty, J Pang, D Chan, G Watts European Journal of Preventive Cardiology 28 (Supplement_1), zwab061. 234, 2021 | | 2021 |
| Cascade Testing for Elevated Lipoprotein (a) in Families With Hypercholesterolaemia A Chakraborty, K Ellis, J Pang, D Chan, G Watts Heart, Lung and Circulation 30, S250, 2021 | | 2021 |
| Cascade testing for elevated lipoprotein (A) in families with familial hypercholesterolaemia A Chakraborty, KL Ellis, J Pang, DC Chan, AJ Hooper, DA Bell, JR Burnett, ... Atherosclerosis 315, e32-e33, 2020 | | 2020 |
